Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.79% | 171.56 | 1.2% | $575.26m | |
| CELG | Celgene Corporation | -0.75% | 88.95 | 1.2% | $554.24m | |
| GILD | Gilead Sciences, Inc. | -0.99% | 73.70 | 0.9% | $441.10m | |
| BIIB | Biogen Inc. | -1.13% | 263.02 | 1.2% | $436.72m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.50% | 314.25 | 2.7% | $242.24m | |
| INCY | Incyte Corporation | -0.90% | 68.43 | 2.5% | $236.48m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.88% | 158.15 | 1.9% | $224.32m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -3.54% | 107.78 | 2.0% | $215.70m | |
| NKTR | Nektar Therapeutics | -4.37% | 86.21 | 6.0% | $196.49m | |
| ILMN | Illumina, Inc. | -0.50% | 244.60 | 3.5% | $185.23m | |
| A | Agilent Technologies, Inc. | -0.63% | 67.54 | 1.5% | $152.87m | |
| ALNY | Alnylam Pharmaceuticals, Inc | 1.34% | 97.48 | 9.8% | $137.98m | |
| BLUE | Bluebird Bio, Inc. | 0.00% | 170.50 | 15.8% | $135.45m | |
| EXAS | Exact Sciences Corporation | 1.54% | 47.52 | 25.7% | $108.85m | |
| BMRN | BioMarin Pharmaceutical Inc. | -1.58% | 82.30 | 4.4% | $107.66m |
Company Profile
Arena Pharmaceuticals, Inc. is a biopharmaceutical company engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers a range of drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.